Last reviewed · How we verify
Ascaricid (hexylresorcinol)
At a glance
| Generic name | hexylresorcinol |
|---|---|
| Drug class | hexylresorcinol |
| Target | Arachidonate 5-lipoxygenase, Tyrosinase, Polyphenol oxidase 2 |
| Therapeutic area | Dermatology |
| Phase | FDA-approved |
Approved indications
Common side effects
Key clinical trials
- Acupuncture for Colorectal sUrgery Recovery Enhancement: A Randomized Controlled Trial Evaluating Gastrointestinal Functional Recovery After Minimally Invasive Resection (NA)
- Efficacy Evaluation of Electroacupuncture in the Treatment of Functional Dyspepsia (NA)
- Effect of Acupuncture and Herbal Medicine on Bowel Recovery After Abdominal Surgery (NA)
- Effect of Thread Embedding Acupuncture on Postoperative Ileus Recovery After Colorectal Cancer Surgery: A Multicenter Randomized Controlled Trial (NA)
- Effect of Electroacupuncture on Opioid-induced Constipation in Patients With Cancer (NA)
- Effect of Acupuncture on Patients With Crohn's Disease in Remission (NA)
- Effect of Acupuncture on Mild to Moderate Active Crohn's Disease (NA)
- Acupuncture for Symptom Relief in Adults with Mild to Moderate Ulcerative Colitis (NA)
Primary sources
Every claim on this page is sourced from regulatory or scientific primary sources. See our editorial policy for full methodology.
| Source | Used for |
|---|---|
| ClinicalTrials.gov | Trial enrolment, design, endpoints, results |
Competitive intelligence
For the full competitive landscape — auto-detected comparators, recent regulatory actions across the set, upcoming PDUFA, patent timeline, sponsor landscape:
- Ascaricid CI brief — competitive landscape report
- Ascaricid updates RSS · CI watch RSS
- portfolio CI